Small-Molecule Injectable Market
The COVID-19 pandemic outbreak has sparked efforts to repurpose already-approved medicines for treatment. Several clinical studies are now being conducted on different antiviral medicines and small-molecule injectables that have been utilized in the past to treat diseases including SARS, MERS, HIV/AIDS, and malaria. For instance, Remdesivir was approved by FDA for the treatment of COVID-19 in hospitalized adult and pediatric patients.
This is expected to fuel sales of small-molecule injectables over the forecast period. Besides this, rising prevalence of chronic illnesses especially cancer and cardiovascular diseases across the globe are anticipated to usher developments in the small-molecule injectables market.
Pharmaceutical companies are aiming at production facility expansions to reduce corporate tax rate (in the U.S.), and to expand their footprints in emerging markets such as India and China, where production cost is low as compared to regions such as Europe and North America.
Recent tax reforms in the U.S., which include reduction of the corporate tax rate, have encouraged various large pharmaceutical and biopharmaceutical companies to invest in production facilities.
Request For Report Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14117
For example, in July 2020, Pfizer announced its plan to invest around US$ 465.0 million to build a sterile injectable plant in Portage, Michigan. This step is a part of its announcement that it made earlier in 2020 about its plans to invest around US$ 5.0 billion in a U.S.-based capital project due to the recent corporate tax reforms in the country. These developments are indicative of lucrative growth prospects for small-molecule injectable market players.
“Increasing adoption of chemotherapy for cancer treatment is expected to propel the small-molecule injectable market growth. In addition to this, fast track drug approvals will continue spurring demand for small-molecule injectables over the forecast period,” says the FMI Analyst.
By product, the analgesics segment is expected to hold 23.9% of the total small-molecule injectable market in 2021, expanding at 8.0% CAGR.
In terms of applications, demand for small-molecule injectables in the infectious disease segment is expected to hold 31.7% of the total market share in 2021.
By route of administration, the intravenous segment is anticipated to hold 50% of the total market share in 2021.
Sales of small-molecule injectables through hospital pharmacies are projected to account for 67.8% of the total market share in 2021.
The U.S. is anticipated to dominate the North America small-molecule injectables market, holding 92.4% of the market share.
Germany is expected to hold of 21.9% of the Europe small-molecule injectable market share by 2031.
Small-molecule injectable market in China is projected to expand at a 9.0% CAGR over the forecast period.
Demand for small-molecule injectables in India is forecast to grow at an impressive 11.1% CAGR through 2031.
Sales of small-molecule injectables in South Korea and Japan are anticipated to rise at 5.0% and 8.8% respectively.
Any Questions about Report, ask us @ https://www.futuremarketinsights.com/ask-question/rep-gb-14117
The key market players covered by FMI include Aurobindo Pharma Limited, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., AstraZeneca Plc, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Novartis AG, Baxter International, Fresenius Kabi, Cipla Ltd, Mylan N.V., Sanofi S.A, and Dr. Reddy’s Laboratories Ltd.
Leading manufacturers of small-molecule injectables are focusing on strategic collaborations and partnerships to strengthen product portfolios. Manufacturers are also aiming at production facility expansions through acquisitions and mergers to gain a competitive edge in the market. For instance:
In September 2020, Aurobindo Pharma USA Inc. acquired commercial operations and three manufacturing facilities in the U.S from Sandoz Inc., USA, and Novartis Division.
In May 2020, Novartis AG received FDA approval for first Piqray - the first and only treatment specifically for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer.
In April 2020, AstraZeneca announced a collaboration with Benevolent AI to use machine learning and artificial intelligence to discover potential new drugs for chronic kidney disease and idiopathic pulmonary fibrosis.
More Insights into the Small-Molecule Injectable Market Report
Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global small-molecule injectable market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights into small-molecule injectable market. The market is segmented into five parts based on product (small molecule antibiotics, chemotherapy agents, local and general anesthetics, skeletal muscle relaxants, analgesics, anticoagulants, anticonvulsants, antivirals, anti-histamines/ anti-allergy, and others), application (oncology, pain management, cardiovascular diseases, infectious diseases, CNS diseases, blood disorders, musculoskeletal disorders, and others), route of administration (intravenous (IV), intramuscular (IM), and subcutaneous (SC)) and distribution channel (hospital pharmacies, retail pharmacies, drug stores, and mail order pharmacies) across seven major regions.
Buy Industry Research Report @ https://www.futuremarketinsights.com/checkout/14117
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: firstname.lastname@example.org
For Media Enquiries: email@example.com
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Small-Molecule Injectable Market here
News-ID: 2489586 • Views: 172
More Releases from Future Market Insights
Automatic Filling Machine Market expanding at a CAGR of 4.6% by the year 2032
The market for automatic filling machines is anticipated to reach a value of US$ 6,619.1 million in 2022 and grow at a moderate CAGR of 4.6% over the same period. By 2032, the market is anticipated to increase to a value of US$10,378.0 million. According to Future Market Insights' analysis, the historical CAGR was 2.6%. Automatic filling machines, which are tools used to fill holding containers like pouches, bags, bottles, and boxes with solid, semi-solid, and liquid product
Market for Gourmet Salts is Expected to Expand at US$ 480.06 Mn by 2032 | FMI
The market for gourmet salts worldwide is predicted to increase at a CAGR of 7.3% over the course of the projected period. It is projected to increase in value from US$ 237.3 Mn in 2022 to US$ 480.06 Mn by 2032. Gourmet salts are unrefined, top quality salts obtained from a natural source with a low sodium content. This salt is used in cuisine to enhance taste of food and also
Lactose-free Cheese Market to Surpass US$ 1.5 Bn by 2032 with Burgeoning Prevale …
According to FMI, the global lactose-free cheese market size is expected to reach a valuation of US$ 676.3 Mn by the end of 2022. The market is set to accelerate at a CAGR of 8.4% during 2022-2032. It is anticipated to be valued at US$ 1,515.1 Mn in 2032. FMI further states that around 35% of the global population was lactose intolerant, and 28% had dairy sensitivity or allergy in 2020.
Electrical Steel Market to grow at a rate of 6.5% by 2031 | Get Customized Repor …
The electrical steel market value will total US$ 37.5 Bn in 2021, as per Future Market Insights (FMI). Exhibiting a CAGR of 6.5% for 2021-2031, the market is expected to reach US$ 70.5 Bn by the end of 2031. Despite logistical challenges amid restrictions imposed to contain the pandemic in 2020, the market is forecast to register 5.3% year-on-year growth in 2021. The demand for electrical steel will surge particularly in
More Releases for FMI
According to FMI, Condition Monitoring Services Will Reach 6.79 Billion USD: FMI
The global condition monitoring service market is anticipated to exceed US$ 3.52 Bn by the end of 2022. Growing emphasis on the integration of condition monitoring software with computerized process control services and maintenance management software is expected to favour the growth in the market. The demand in the condition monitoring service global market is estimated to reach US$ 6.79 Bn by 2031, exhibiting growth at a CAGR of 9.8% during
Medication Dispenser Market Forecast and Analysis by FMI
According to Wikipedia, medication or pill dispenser is an equipment which releases medication at specified time. In simple language, an equipment gives a signal when the time comes to take the medicine. The purpose is to help senior citizens or people who may suffer from impaired ability to adhere to their prescribed medication regime. The device automatically releases the pre-measured dose into a small compartment that is easily opened and
Printing Paper Market Intelligence and Forecast by FMI
Global printing paper market: Introduction The global paper industry is undergoing rapid transformation and plays significant role in the global packaging industry. In addition to manufacturing of packaging products such as corrugated boxes, paperboards or envelopes, papers are also used for the production of printing paper for printing purposes. Printing paper market is anticipated to grow on the backdrop of packaging industry, printing industry, and as well as e-commerce industry
Pharmaceutical Solvent Market Forecast and Prospectus : FMI Research
Global Market for Pharmaceutical Solvents Projected to Witness Sluggish Growth A majority of medicines & drugs produced in the world are derived from formulating Active Pharmaceutical Ingredients (API), and such processes require alcoholic solvents such as ethanol, isopropanol, propanol and propylene glycol. Production of pharmaceutical solvents continues to be concentrated in the Asia-Pacific excluding Japan (APEJ) region as leading API suppliers and drug manufacturers in the world have based their production units
Temperature Controlled Packaging Solutions Market Analysis : FMI
While North America will continue to be the most attractive market, the temperature controlled packaging solutions market in Asia Pacific excluding Japan (APEJ) will witness steady gains. According to a comprehensive analysis on the global temperature controlled packaging solutions market by Future Market Insights, companies seeking thermally-regulated packaging solutions for unhampered delivery of their products will continue to opt for insulated containers, with chest-type containers accounting for significant demand. However, during
Force Sensor Market Share, Value, Trends : FMI Report
Continuous adoption of force sensors as human-machine interface is projected to pave new business opportunities for force sensor manufacturers among various industries such as music & entertainment. In addition, surging implementation of various ICT technologies in healthcare, and rising necessity to improve quality of healthcare services are further expected to offer growth opportunities to developers of force sensing technology. Future Market insights (FMI), in its report, projects the global market